期刊文献+

hnRNP B1 mRNA在非小细胞肺癌患者外周血中手术前后的表达变化及临床意义

Clinical Significance of Expression of Peripheral Blood hnRNP B1 mRNA in NSCLC Patients
下载PDF
导出
摘要 目的探讨hnRNPB1mRNA在非小细胞肺癌患者外周血中手术前后表达水平的变化及其临床意义。方法采用Realtime FQ-RT-PCR方法检测30例非小细胞肺癌患者手术前第3天和手术后第3、5、10天外周血中hnRNPB1mRNA的含量。结果非小细胞肺癌患者外周血中检测的hnRNPB1mRNA手术前第3天和手术后第5、10天的ΔΔCt值比较P为0.00,差异有统计学意义(P<0.05),手术前和手术后第3天的ΔΔCt值比较P为0.12,差异无统计学意义(P>0.05);手术前和手术后第3天鳞癌与其他病理类型肺癌ΔΔCt值比较P值分别为0.02和0.01,差异有统计学意义,而手术前后不同性别、不同病理分期和有无淋巴结转移组间以及手术后第5天和第10天不同病理类型的ΔΔCt值差异无统计学意义(P>0.05)。结论 hnRNPB1mRNA在非小细胞肺癌患者手术后外周血中的表达水平随时间推移逐渐下降,这种变化可以用来监测非小细胞肺癌患者的手术治疗效果和判断预后,并有可能用以术后监测肿瘤复发。另外hnRNPB1mRNA在非小细胞肺癌患者手术前和手术后早期外周血中的表达水平与病理类型有一定的关系。 Objective To investigate clinical significance of the expression of peripheral blood hnRNP B1(Heterogeneous nuclear ribonucleoprotein B1) mRNA in NSCLC patients.Method The peripheral blood hnRNP B1 mRNA was detected in 30 NSCLC patients at the third day pre-operation and third day,fifth day,tenth day after operation by real time FQ-RT-PCR.Results The ΔΔCt value of peripheral blood hnRNP B1 mRNA of third day before operation in NSCLC patients was significantly different from fifth and tenth day after operation(P0.05),and the same as that of third day after operation.Meantime,there was no significant difference between the ΔΔCt value of fifth day and tenth day post-operation(P0.05).The ΔΔCt values of squamous cell carcinoma at the third day before and after operation was significantly different from other pathological types.Whereas,the ΔΔCt vere not related with gender,pathological stage or lymph node metastasis.Conclusion The expression level of peripheral blood hnRNP B1 mRNA in NSCLC patients was gradually decreased after operation with a time-dependent manner,which was useful to monitor the therapeutic efficacy and evaluate prognosis or the relapse of tumor.Expression level of peripheral blood hnRNP B1 mRNA in NSCLC patients was related with pathological types.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第10期1152-1155,共4页 Cancer Research on Prevention and Treatment
关键词 非小细胞肺癌 核内不均一核糖核蛋白 外科治疗 Non small-cell lung cancer Heterogeneity ribonucleoprotein Surgical therapy
  • 相关文献

参考文献16

  • 1Sueoka E, Sueoka N, Goto Y, et al. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia[J].Cancer Res,2001,61 (5) : 1896-1902.
  • 2Tockman MS, Mulshine JL, Piantadosi S, et al. Pro spective detection of preclinical lung cancer: results from two studies of HnRNP expression[J]. Clin Cancer Res, 1997, 3(12) :2237- 2246.
  • 3Tominaga M, Sueoka N, Irie K, et al. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67 [J].Lung Cancer, 2003,40 ( 1 ) : 45-53.
  • 4Wu SL, Sato M, Endo C, et al. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung[J].Lung Cancer,2003,41(2) : 179-186.
  • 5Pino I, Pio R, Toledo G, et al. Altered patterns of expression of members of the heterogeneous nuclear ribonucleop rotein (hnRNP) family in lung cancer[J]. Lung Cancer, 2003,41 (2): 131-143.
  • 6Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection ofpreclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression[J].Clin Cancer Res,1997,3(12) :2237-2246.
  • 7Fielding P, Turnbull L, Prime W, et al. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens:A clinicalm arkerof early lung cancer detection [J]. Clin Cancer Res, 1999,5 (12) :4048-4052.
  • 8ManY G, M artinez A, Ingalill M, et al. Phenotypically diferent cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations[J]. Am J Respit Cell Mol Biol,2000,23 (50):636-645.
  • 9Hiraki A, Murakami T, Aoe K, et al. Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma [J]. Cancer Sci,2006,97(11 ) : 1175-1181.
  • 10Fleischhacker M, Beinert T, Ermitsch M, Seferi D, Possinger K, Engelmann C, et al. Detection of amplifiable messenger RNA in the serum of patients with lung cancer[J]. Ann N Y Acad Sci, 2001,945(1) : 179-188.

二级参考文献30

  • 1[2]Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res,1997,3(12 Pt 1):2237-2246.
  • 2[3]Sueoka E, Goto Y, Sueoka N, et al. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res,1999,59(7):1404-1407.
  • 3[4]Fielding P, Turnbull L, Prime W, et al. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res,1999,5(12):4048-4052.
  • 4[5]Sueoka E, Sueoka N, Goto Y, et al. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia. Cancer Res,2001,61(5):1896-1902.
  • 5[6]Ford LP, Suh JM, Wright WE, et al. Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase. Mol Cell Biol,2000,20(23):9084-9091.
  • 6[7]Matsuyama S, Goto Y, Sueoka N, et al. Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis. Jpn J Cancer Res,2000,91(6):658-663.
  • 7[8]Goto Y, Sueoka E, Chiba H, et al. Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma. Jpn J Cancer Res,1999,90(12):1358-1363.
  • 8[9]Zhou J, Allred DC, Avis I, et al. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat,2001,66(3):217-224.
  • 9[10]Montuenga LM, Zhou J, Avis I, et al. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development. Am J Respir Cell Mol Biol,1998,19(4):554-562.
  • 10[11]Zhou J, Mulshine JL, Ro JY, et al. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res,1998,4(7):1631-1640.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部